AMP Events Calendar

09/30: From variants to value

1 p.m. Eastern on Sept. 30

From variants to value: The expanding role of clinical bioinformatics

Speaker: Srika Chamala, Ph.D., Children's Hospital of Los Angeles & University of Southern California

Moderator: Rebecca Yee, Ph.D., George Washington University

10/09: Cell-free DNA from CSF

Oct. 9 at 1 p.m. Eastern

Cell-free DNA from cerebrospinal fluid for diagnosis and molecular testing of brain tumors

Speaker: Tejus A. Bale, M.D., Ph.D., Memorial Sloan Kettering Cancer Center

Moderator: Pawel Mroz, M.D., Ph.D., University of Minnesota Medical School

10/16: Developing Consensus for a More Provider-Friendly NGS Molecular Biomarker Report

3 p.m. on Oct. 16, 2025

Developing Consensus for a More Provider-Friendly Next-Generation Sequencing Molecular Biomarker Report

Speaker: Jane Gibson, Ph.D., University of Central Florida College of Medicine

Moderator: Anthony Snow, M.D., University of Iowa Hospitals and Clinics

10/21: Introduction to Molecular Biomarkers: Evidence and Guidelines

4 p.m. Eastern on Oct. 21, 2025

Introduction to Molecular Biomarkers: Evidence and Guidelines

Speakers:

Eric Vail, M.D., Cedars–Sinai Medical Center

Paul M. Waring, Ph.D., Translational Pathology Consulting Services

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.

10/27: Molecular Testing Strategies and Evaluation of Assay Performance

4 p.m. Eastern on Oct. 27, 2025

Molecular Testing Strategies and Evaluation of Assay Performance

Speakers:

Katherine B. Geiersbach, M.D., Mayo Clinic

Shuko Harada, M.D., University of Alabama at Birmingham

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.

10/30: Applying Molecular Testing in Practice with Case Discussions and Expert Panel

2 p.m. Eastern on Oct. 30, 2025

Applying Molecular Testing in Practice with Case Discussions and Expert PanelSpeakers:

Speaker: Karthik Giridhar, M.D., Mayo Clinic

This webinar is part of the Current Concepts in Molecular Testing for HR+/HER2- Metastatic Breast Cancer series.